- Report
- August 2022
- 134 Pages
Asia Pacific
From €1369EUR$1,500USD£1,163GBP
- Report
- January 2022
- 182 Pages
Global
From €3285EUR$3,600USD£2,791GBP
- Report
- January 2022
- 83 Pages
Europe
From €1369EUR$1,500USD£1,163GBP
- Report
- January 2022
- 75 Pages
North America
From €1369EUR$1,500USD£1,163GBP
- Report
- January 2022
- 84 Pages
Asia Pacific
From €1369EUR$1,500USD£1,163GBP
- Report
- January 2022
- 84 Pages
Africa, Middle East
From €1369EUR$1,500USD£1,163GBP
- Report
- September 2022
- 33 Pages
Global
From €908EUR$995USD£771GBP
- Report
- March 2025
- 87 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- September 2024
- 98 Pages
Global
From €3500EUR$4,109USD£3,078GBP
- Report
- November 2021
- 527 Pages
Global
From €3650EUR$4,000USD£3,101GBP
- Report
- May 2022
- 205 Pages
Global
From €2208EUR$2,419USD£1,876GBP
€3154EUR$3,456USD£2,680GBP
- Report
- December 2021
- 170 Pages
Global
From €2371EUR$2,598USD£2,015GBP
€3387EUR$3,712USD£2,878GBP

RNA therapy is a form of gene therapy that uses RNA molecules to treat or prevent diseases. It is a type of genomics-based therapy that works by introducing genetic material into cells to modify their behavior. RNA therapy can be used to treat a variety of diseases, including cancer, neurological disorders, and infectious diseases. It has the potential to be used to treat genetic disorders, as well as to modify the expression of genes in order to improve the effectiveness of existing treatments.
RNA therapy works by introducing genetic material into cells, which can then be used to modify the expression of genes. This can be done by introducing a gene that produces a therapeutic protein, or by introducing a gene that silences a gene that is causing a disease. RNA therapy can also be used to modify the expression of existing genes, which can be used to improve the effectiveness of existing treatments.
RNA therapy is an emerging field of genomics-based therapy, and is being explored by a number of companies. Examples of companies in the RNA therapy market include Moderna, BioNTech, and Arcturus Therapeutics. Show Less Read more